Articles

Stem cell advance on arterial front

New techniques have produced first functional arterial cells relevant for disease modeling and clinic
Written byJeffrey Bouley
| 4 min read

MADISON, Wis.—Stem cells have, of course, offered (and continue to offer) much promise and potential over the years—as well as some practical uses already in therapeutics—but it is that potential that is often the rub in life-sciences research and pharma/biotech. The end goal, whether disease modeling or therapeutics or something else, is visible, but the path to get there turns out to be quite a bit less easily navigable than researchers might have hoped.

One important area in which researchers have as yet been unsuccessful is in the effort to produce cells that will ultimately create functional arteries. The ability to give rise to healthy arteries from stem cells would be a huge boost in fighting cardiovascular disease.

As Brian Mattmiller wrote recently for the Morgridge Institute for Research website, new techniques developed at a Morgridge Institute for Research and the University of Wisconsin-Madison (UW-Madison) have produced, for the first time, functional arterial cells at both the quality and scale to be relevant for disease modeling and clinical application.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.